07:00 - 08:15 | 335 | MS6 Severe asthma: diagnosis and treatment | Morning Seminar |
07:00 - 08:15 | 336 | MS4 Interpreting high-resolution computed tomography scans: top tips | Morning Seminar |
08:30 - 10:30 | 338 | Respiratory infectious diseases Grand Round: an interactive session | Grand round |
08:30 - 10:30 | 339 | Paediatric Year in Review | Session |
08:30 - 10:30 | 340 | Genetics and genomics in asthma and COPD: prediction and personalised medicine | Symposium |
08:30 - 10:30 | 341 | ERS Award for Rare Pulmonary Disease Ceremony (supported by GlaxoSmithKline) followed by symposium "Update on orphan lung diseases" | Symposium |
08:30 - 10:30 | 342 | Non-antibiotic effects of macrolides in lung disease | Symposium |
08:30 - 10:30 | 343 | Sex-related differences in pulmonary disease | Symposium |
08:30 - 10:30 | 344 | Biology and treatment of malignant pleural effusions | Oral Presentation |
08:30 - 10:30 | 345 | New bronchodilators and other novel drugs for asthma and COPD | Oral Presentation |
08:30 - 10:30 | 346 | The best abstracts in chronic care | Oral Presentation |
08:30 - 10:30 | 347 | Stem cells and progenitors in injury and repair | Oral Presentation |
08:30 - 10:30 | 348 | Act to change tobacco epidemics | Oral Presentation |
08:30 - 10:30 | 349 | Immunologic mechanisms in COPD and asthma | Oral Presentation |
08:30 - 10:30 | 350 | Pulmonary manifestations of systemic diseases | Oral Presentation |
08:30 - 10:30 | 351 | Epidemiology and care research of lung cancer | Poster Discussion |
08:30 - 10:30 | 352 | Idiopathic pulmonary fibrosis | Poster Discussion |
08:30 - 10:30 | 353 | Pulmonary circulation: basic mechanisms, animal models and cell biology | Poster Discussion |
08:30 - 10:30 | 354 | Physiology, obesity and the downstream effects of OSA | Poster Discussion |
08:30 - 10:30 | 355 | Predicting the future: the impact of reference values on a range of respiratory paramaters | Poster Discussion |
08:30 - 10:30 | 356 | COPD monitoring in stable disease and during exacerbation | Poster Discussion |
10:45 - 12:45 | 358 | Research Award on Idiopathic Pulmonary Fibrosis Ceremony (supported by InterMune) followed by Clinical Grand Round - an interactive session | Grand round |
10:45 - 12:45 | 359 | The promise of new drugs for treating asthma and COPD | Symposium |
10:45 - 12:45 | 360 | Modelling respiratory infections: is it the future or the present? | Symposium |
10:45 - 12:45 | 361 | COPD in non-smokers: an important neglected disease | Symposium |
10:45 - 12:45 | 362 | The updated ATS/ERS statement on pulmonary rehabilitation - update from the ATS/ERS Task Force | Hot topics |
10:45 - 12:45 | 363 | EBUS-TBNA: a never ending story | Oral Presentation |
10:45 - 12:45 | 364 | Treatment of lung cancer | Oral Presentation |
10:45 - 12:45 | 365 | Pulmonary circulation: clinical treatment | Oral Presentation |
10:45 - 12:45 | 366 | Treating childhood asthma | Oral Presentation |
10:45 - 12:45 | 367 | Cardiovascular disease and sleep-disordered breathing | Oral Presentation |
10:45 - 12:45 | 368 | New developments in paediatric respiratory physiology | Oral Presentation |
10:45 - 12:45 | 369 | Pre-operative evaluation in thoracic surgery | Oral Presentation |
10:45 - 12:45 | 370 | Lung, heart, muscles and brain: the pathway of oxygen during exercise in health and COPD | Oral Presentation |
10:45 - 12:45 | 371 | MDR- and XDR-TB: clinical and public health experiences | Poster Discussion |
10:45 - 12:45 | 372 | Paediatric bronchology | Poster Discussion |
10:45 - 12:45 | 373 | Medical access to the pleura | Poster Discussion |
10:45 - 12:45 | 374 | Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis | Poster Discussion |
10:45 - 12:45 | 375 | Environmental exposure and other risk factors for airway diseases | Poster Discussion |
10:45 - 12:45 | 376 | Cellular signalling mechanisms in the airways | Poster Discussion |
12:50 - 14:40 | 377 | Asthma management | Thematic Poster Session |
12:50 - 14:40 | 378 | COPD: epidemiology and varia | Thematic Poster Session |
12:50 - 14:40 | 379 | COPD treatment and varia | Thematic Poster Session |
12:50 - 14:40 | 380 | New insights in the clinical management of lung diseases | Thematic Poster Session |
12:50 - 14:40 | 381 | The good clinical practice: useful case report | Thematic Poster Session |
12:50 - 14:40 | 382 | New adjuncts and modalities in pulmonary rehabilitation | Thematic Poster Session |
12:50 - 14:40 | 383 | The latest insights in pulmonary rehabilitation | Thematic Poster Session |
12:50 - 14:40 | 384 | CT findings: educational posters | Thematic Poster Session |
12:50 - 14:40 | 385 | The broad spectrum of diagnostic bronchoscopy | Thematic Poster Session |
12:50 - 14:40 | 386 | The different ways to establish a diagnosis: needle and forcep | Thematic Poster Session |
12:50 - 14:40 | 387 | Diffuse parenchymal lung disease I | Thematic Poster Session |
12:50 - 14:40 | 388 | Diffuse parenchymal lung disease II | Thematic Poster Session |
12:50 - 14:40 | 389 | Diffuse parenchymal lung disease III | Thematic Poster Session |
12:50 - 14:40 | 390 | Diffuse parenchymal lung disease IV | Thematic Poster Session |
12:50 - 14:40 | 391 | Distinguishing phenotypes and dealing with comorbidities in primary care | Thematic Poster Session |
12:50 - 14:40 | 392 | Molecular biology of pro- and anti-inflammatory responses in the lung | Thematic Poster Session |
12:50 - 14:40 | 393 | Cell culture and animal models of lung disease | Thematic Poster Session |
12:50 - 14:40 | 394 | Fibrogenesis between epithelial injury and fibroblast proliferation | Thematic Poster Session |
12:50 - 14:40 | 395 | Lung injury and repair: reactive oxygen species and beyond | Thematic Poster Session |
12:50 - 14:40 | 396 | Various issues in clinical physiology | Thematic Poster Session |
12:50 - 14:40 | 397 | Metabolic and cardiovascular consequences of OSA I | Thematic Poster Session |
12:50 - 14:40 | 398 | Clinical predictors of OSA, adherence to CPAP and psychology | Thematic Poster Session |
12:50 - 14:40 | 399 | Sleep apnoea: clinical topics | Thematic Poster Session |
12:50 - 14:40 | 400 | Metabolic and cardiovascular consequences of OSA II | Thematic Poster Session |
12:50 - 14:40 | 401 | Pulmonary circulation: acute and chronic pulmonary embolism | Thematic Poster Session |
12:50 - 14:40 | 402 | Pulmonary circulation: basic mechanisms, animal models and experimental treatments | Thematic Poster Session |
12:50 - 14:40 | 403 | Pulmonary circulation: clinical end-points and clinical physiology | Thematic Poster Session |
12:50 - 14:40 | 404 | Epidemiology of asthma | Thematic Poster Session |
12:50 - 14:40 | 405 | Methodology in epidemiologic research | Thematic Poster Session |
12:50 - 14:40 | 406 | Epidemiology of various respiratory diseases | Thematic Poster Session |
12:50 - 14:40 | 407 | COPD beyond tobacco | Thematic Poster Session |
12:50 - 14:40 | 408 | Abestosis, silicosis and hypersensitivity pneumonitis | Thematic Poster Session |
12:50 - 14:40 | 409 | Tobacco cessation | Thematic Poster Session |
12:50 - 14:40 | 410 | Tobacco and shisha exposure in children and adolescents | Thematic Poster Session |
12:50 - 14:40 | 411 | Tobacco comorbidity | Thematic Poster Session |
12:50 - 14:40 | 412 | Assessing and treating childhood asthma and allergy | Thematic Poster Session |
12:50 - 14:40 | 413 | Airway infections in children: from risk factors to treatment | Thematic Poster Session |
12:50 - 14:40 | 414 | Issues in neonatal and paediatric intensive care | Thematic Poster Session |
12:50 - 14:40 | 415 | Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation | Thematic Poster Session |
12:50 - 14:40 | 416 | Prognosis of lung cancer | Thematic Poster Session |
12:50 - 14:40 | 417 | Screening, diagnosis, staging and treatment strategies for lung cancer | Thematic Poster Session |
12:50 - 14:40 | 418 | New biomarkers for lung cancer | Thematic Poster Session |
13:00 - 14:30 | 419 | ERS COPD exacerbation guidelines: methodologies and overview | Symposium |
13:00 - 14:30 | 420 | Is it time to bring pre-school lung function testing to the clinic? Update from the ATS/ERS Task Force | Symposium |
13:00 - 14:30 | 421 | Pro/Con Debate "Cost-effectiveness of maintenance chemotherapy for NSCLC" | Symposium |
13:00 - 14:30 | 422 | The European Respiratory Review: what's hot in pulmonary medicine | Symposium |
13:15 - 14:30 | 428 | Bronchial Thermoplasty: a life changing therapy for persistent asthma patients | Practical Workshop |
13:15 - 14:30 | 429 | Secretion Management in chronic respiratory insufficiency - state of the art and perspectives | Practical Workshop |
14:45 - 16:45 | 434 | Update on Tallinn summit: health inequalities in Europe | Symposium |
14:45 - 16:45 | 435 | Ceremony for Pulmonary Arterial Hypertension Award (supported by Actelion) followed by Clinical Year in Review II | Session |
14:45 - 16:45 | 436 | Good quality clinical recommendations for thoracic malignancy management in Europe | Symposium |
14:45 - 16:45 | 437 | Impact of traffic-related pollution on children's lungs | Symposium |
14:45 - 16:45 | 438 | ERS Romain Pauwels Research Award Ceremony (supported by GlaxoSmithKline) followed by the Hot Topic "The nerves are back!" | Hot topics |
14:45 - 16:45 | 439 | Pros and cons of MDR- and XDR-TB treatment | Oral Presentation |
14:45 - 16:45 | 440 | Acute exacerbation in COPD | Oral Presentation |
14:45 - 16:45 | 441 | Exhaled biomarkers to assess airway inflammation | Oral Presentation |
14:45 - 16:45 | 442 | Paediatrics and sleep apnoea/adults and upper airway stimulation | Oral Presentation |
14:45 - 16:45 | 443 | Novel mechanisms of acute lung injury | Oral Presentation |
14:45 - 16:45 | 444 | Patient views on respiratory allergies: raise awareness, release the burden (organised jointly by ELF/EFA) | Symposium |
14:45 - 16:45 | 445 | Life's a gas: aspects of respiratory gas exchange | Oral Presentation |
14:45 - 16:45 | 446 | Effectiveness of respiratory disease management in primary care | Oral Presentation |
14:45 - 16:45 | 447 | Respiratory diseases at at work: epidemiology, inflammation and challenge studies | Poster Discussion |
14:45 - 16:45 | 448 | Anti-infective treatment and resistance in respiratory infections | Poster Discussion |
14:45 - 16:45 | 449 | Outcomes and assessment methods in physiotherapy and rehabilitation | Poster Discussion |
14:45 - 16:45 | 450 | Progress in endoscopy for lung cancer | Poster Discussion |
14:45 - 16:45 | 451 | Special problems in thoracic surgery | Poster Discussion |
14:45 - 16:45 | 452 | Limiting factors in exercise | Poster Discussion |